Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dyke, J.P. Articles by Ballon, D. Search for Related Content PubMed PubMed Citation Articles by Dyke, J.P. Articles by Ballon, D.

American Journal of Neuroradiology 28:1232-1236, August 2007
DOI 10.3174/ajnr.A0551
© 2007 American Society of Neuroradiology

PEDIATRICS

Assessing Disease Severity in Late Infantile Neuronal Ceroid Lipofuscinosis Using Quantitative MR Diffusion-Weighted Imaging

J.P. Dyke^a,b, H.U. Voss^a,b, D. Sondhi^c, N.R. Hackett^c, S. Worgall^d, L.A. Heier^b, B.E. Kosofsky^d, A.M. Ulu^b, D.C. Shungu^a,b, X. Mao^a,b, R.G. Crystal^c and D. Ballon^a,b

^a Citigroup Biomedical Imaging Center, Weill Medical College of Cornell University, New York, NY
^b Department of Radiology, Weill Medical College of Cornell University, New York, NY
^c Department of Genetic Medicine, Weill Medical College of Cornell University, New York, NY
^d Department of Pediatrics, Weill Medical College of Cornell University, New York, NY

Address correspondence to Jonathan P. Dyke, Citigroup Biomedical Imaging Center, Weill Cornell Medical College, Box 234, 1300 York Ave, New York, NY 10021; e-mail: jpd2001{at}med.cornell.edu

BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (LINCL), a form of Batten disease, is a fatal neurodegenerative genetic disorder, diagnosed via DNA testing, that affects approximately 200 children in the United States at any one time. This study was conducted to evaluate whether quantitative data derived by diffusion-weighted MR imaging (DWI) techniques can supplement clinical disability scale information to provide a quantitative estimate of neurodegeneration, as well as disease progression and severity.

MATERIALS AND METHODS: This study prospectively analyzed 32 DWI examinations from 18 patients having confirmed LINCL at various stages of disease. A whole-brain apparent diffusion coefficient (ADC) histogram was fitted with a dual Gaussian function combined with a function designed to model voxels containing a partial volume fraction of brain parenchyma versus CSF. Previously published whole-brain ADC values of age-matched control subjects were compared with those of the LINCL patients. Correlations were tested between the peak ADC of the fitted histogram and patient age, disease severity, and a CNS disability scale adapted for LINCL.

RESULTS: ADC values assigned to brain parenchyma were higher than published ADC values for age-matched control subjects. ADC values between patients and control subjects began to differ at 5 years of age based on 95% confidence intervals. ADC values had a nearly equal correlation with patient age (R² = 0.71) and disease duration (R² = 0.68), whereas the correlation with the central nervous system disability scale (R² = 0.27) was much weaker.

CONCLUSION: This study indicates that brain ADC values acquired using DWI may be used as an independent measure of disease severity and duration in LINCL.